Innate Pharma SA reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Marseille
SEC filing record 1 source field available
Fiscal year end
31 December
Innate Pharma SA has filed 337 SEC EDGAR filings since 31 Jan 2014

SEC filing history

Showing 176-200 of 337 matching filings.

Per page
25
Current page
8
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
06 Apr 2023
Reporting date
06 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
23 Mar 2023
Reporting date
23 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
20 Mar 2023
Reporting date
20 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
16 Mar 2023
Reporting date
16 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
13 Mar 2023
Reporting date
13 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
21 Feb 2023
Reporting date
21 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
07 Feb 2023
Reporting date
07 Feb 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
25 Jan 2023
Reporting date
25 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
17 Jan 2023
Reporting date
16 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
19 Dec 2022
Reporting date
19 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
12 Dec 2022
Reporting date
12 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
12 Dec 2022
Reporting date
10 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
09 Dec 2022
Reporting date
09 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91173

SC 13D/A

Filing date
06 Dec 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
01 Dec 2022
Reporting date
01 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
14 Nov 2022
Reporting date
14 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
07 Nov 2022
Reporting date
04 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
04 Nov 2022
Reporting date
03 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
02 Nov 2022
Reporting date
02 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91173

SC 13D/A

Filing date
21 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
20 Oct 2022
Reporting date
20 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-39084

INNATE PHARMA S.A. 6-K

Filing date
23 Sep 2022
Reporting date
23 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .